Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - CASH FROM OPERATIONS
Cash from Operations ESPR - Esperion Therapeutics, Inc.
-135 M
LAST VALUE
28.34%
2 YEAR CAGR
1.84%
5 YEAR CAGR
-22.29%
10 YEAR CAGR